T. Rowe Price Associates
CELG

T. Rowe Price Associates’s Celgene Corp CELG Stock Holding History

T. Rowe Price Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,302,695
Closed -$129M – 2604
2019
Q3 		$129M Sell
1,302,695
-741,178
-36% -$70.4M 0.02% 545
2019
Q2 		$189M Sell
2,043,873
-1,977,466
-49% -$188M 0.03% 479
2019
Q1 		$379M Sell
4,021,339
-991,112
-20% -$86.7M 0.06% 311
2018
Q4 		$321M Sell
5,012,451
-4,902,423
-49% -$362M 0.05% 319
2018
Q3 		$887M Buy
9,914,874
+6,622,724
+201% +$585M 0.13% 173
2018
Q2 		$261M Buy
3,292,150
+71,252
+2% +$5.92M 0.04% 401
2018
Q1 		$287M Sell
3,220,898
-4,962,763
-61% -$476M 0.05% 377
2017
Q4 		$854M Sell
8,183,661
-3,036,847
-27% -$343M 0.14% 162
2017
Q3 		$1.64B Sell
11,220,508
-1,153,174
-9% -$157M 0.28% 83
2017
Q2 		$1.61B Sell
12,373,682
-2,383,169
-16% -$292M 0.29% 83
2017
Q1 		$1.84B Sell
14,756,851
-1,589,173
-10% -$190M 0.34% 67
2016
Q4 		$1.89B Sell
16,346,024
-1,661,133
-9% -$185M 0.38% 64
2016
Q3 		$1.88B Sell
18,007,157
-746,559
-4% -$80.8M 0.38% 60
2016
Q2 		$1.85B Sell
18,753,716
-3,044,808
-14% -$315M 0.39% 54
2016
Q1 		$2.18B Sell
21,798,524
-4,477,414
-17% -$461M 0.47% 40
2015
Q4 		$3.15B Sell
26,275,938
-1,895,528
-7% -$219M 0.66% 28
2015
Q3 		$3.05B Buy
28,171,466
+528,991
+2% +$65.6M 0.68% 25
2015
Q2 		$3.2B Sell
27,642,475
-126,645
-0.5% -$14.5M 0.66% 24
2015
Q1 		$3.2B Buy
27,769,120
+744,643
+3% +$89M 0.66% 22
2014
Q4 		$3.02B Sell
27,024,477
-188,386
-0.7% -$19.9M 0.64% 22
2014
Q3 		$2.58B Buy
27,212,863
+563,522
+2% +$50.9M 0.56% 35
2014
Q2 		$2.29B Buy
26,649,341
+251,673
+1% +$19.1M 0.49% 41
2014
Q1 		$1.84B Sell
26,397,668
-1,782,144
-6% -$141M 0.41% 51
2013
Q4 		$2.38B Sell
28,179,812
-500,614
-2% -$39.6M 0.55% 30
2013
Q3 		$2.21B Buy
28,680,426
+768,026
+3% +$53.8M 0.55% 32
2013
Q2 		$1.63B Buy
+27,912,400
New +$1.68B 0.44% 48

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

T. Rowe Price Associates's CELG Position: Q4 2019 in Review

T. Rowe Price Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,302,695 shares — an estimated $129M sold.

T. Rowe Price Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.2B in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • T. Rowe Price Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,302,695 Celgene Corp shares in Q4 2019, an estimated $129M.
  • T. Rowe Price Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • T. Rowe Price Associates's Celgene Corp position peaked at $3.2B in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.